BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

View Full Size 

Download

• Full Size JPEG, 1476x542, 211.5 KB
• Small JPEG, 480x176, 39.3 KB
• Preview JPEG, 144x53, 6.5 KB
• Thumbnail JPEG, 120x44, 4.7 KB